UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): April 21, 2004 (April 21, 2004)
ENDO PHARMACEUTICALS HOLDINGS INC.
DELAWARE
|
01-15989 | 13-4022871 | ||
(State or other
jurisdiction of
incorporation)
|
(Commission File Number) | (I.R.S. Employer Identification No.) | ||
100 Painters Drive Chadds Ford, Pennsylvania |
19317 | |||
(Address of principal executive offices)
|
(Zip Code) | |||
(610) 558-9800
N/A
| Item 7. Financial Statements and Exhibits. | ||||||||
| Item 12. Results of Operations and Financial Condition. | ||||||||
| SIGNATURES | ||||||||
| INDEX TO EXHIBITS | ||||||||
| PRESS RELEASE | ||||||||
| Item 7. | Financial Statements and Exhibits. |
| (a) | Financial Statements of Businesses Acquired. |
Not applicable.
| (b) | Pro Forma Financial Information. |
Not applicable.
| (c) | Exhibits. |
| Exhibit Number |
Description |
|
99.1
|
Press Release of Endo Pharmaceuticals Holdings Inc. dated April 21, 2004, reporting the Registrant’s financial results of the quarter ended March 31, 2004 |
| Item 12. | Results of Operations and Financial Condition. |
The following information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.
On April 21, 2004, the Registrant issued an earnings release announcing its financial results for the quarter ended March 31, 2004. A copy of the earnings release is furnished as Exhibit 99.1 and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ENDO PHARMACEUTICALS HOLDINGS INC. (Registrant) |
||||
| By: | /S/ CAROL A. AMMON | |||
| Name: | Carol A. Ammon | |||
| Dated: April 21, 2004 | Title: | Chairman & Chief Executive Officer | ||